Moderna, Inc. (0A45.IL)
Develops messenger RNA vaccines and treatments for diseases like COVID-19 and cancer.
$55.45+0.02%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+104.0%
The outlook
Moderna is trading near the middle of its 52-week range at $55.45, with a trailing P/E of 20.7. Price action is mixed against moving averages, and analyst sentiment leans slightly bullish overall. The stock shows neither strong momentum nor significant weakness at current levels.
What’s behind the score
Price trendMixed vs its moving averages
52-week range52% of the way from its 52-week low to high
Market cap
$26.96B
52-wk high
$85.63
52-wk low
$22.25
50-day avg
$58.79
200-day avg
$45.19
Trailing P/E
20.7